Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Thursday, June 20, 2019 · 488,572,163 Articles · 3+ Million Readers

Silk Road Medical to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference

SUNNYVALE, Calif., June 11, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference in New York, NY.

/EIN News/ -- Silk Road Medical’s management is scheduled to present on Tuesday, June 25 at 10:40 a.m. Eastern Time.  Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/.

About Silk Road Medical
Silk Road Medical, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke.

Investor Contact:
Lynn Lewis or Carrie Mendivil
investors@silkroadmed.com

 

silkroad_logo.jpg

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release